Market Cap 17.58B
Revenue (ttm) 20.67B
Net Income (ttm) 3.20B
EPS (ttm) N/A
PE Ratio 12.78
Forward PE 12.25
Profit Margin 15.49%
Debt to Equity Ratio 2.28
Volume 469,243
Avg Vol 1,098,290
Day's Range N/A - N/A
Shares Out 87.89M
Stochastic %K 34%
Beta 1.53
Analysts Strong Sell
Price Target $233.75

Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, mu...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 469 893 2200
Address:
14201 Dallas Parkway, Dallas, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:36 AM
$THC is currently trading at $196.66, with an RSI of 38.86 indicating potential oversold conditions. The price is below both the 30-day moving average (MA30) of 202.2 and the 50-day moving average (MA50) of 199.08, suggesting a bearish trend. The recent high of $217.43 and low of $177.36 over the past 60 days further illustrate a significant range, indicating volatility. Given the current metrics, the directional bias leans bearish, but the oversold RSI may provide a short-term bounce opportunity. Suggested trade plan: - Entry: $195.00 (anticipating a rebound) - Stop: $190.00 (to limit downside risk) - Target 1: $202.00 (near MA30) - Target 2: $207.00 (mid-range between recent high and current price) Monitor for any changes in momentum or market conditions that could affect these levels. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 11:10 PM
So far, several companies have been raising guidance this earnings season 🔥, a list that includes $AXP, $W, and $THC. 📈 https://www.zacks.com/stock/quote/AXP?q=axp&cid=sm-stocktwits-1-quote_overview-oc-21002&ADID=SYND_STOCKTWITS_TWEET_1_QUOTEOVERVIEW_OC_21002
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:58 PM
JP Morgan has updated their rating for Tenet Healthcare ( $THC ) to Overweight with a price target of 230.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 3:34 PM
Wells Fargo updates rating for Tenet Healthcare ( $THC ) to Overweight, target set at 238 → 252.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:43 AM
$THC is currently trading at $197.96, showing a neutral market context with an RSI of 44.18, indicating a lack of momentum. The price is below both the 30-day moving average (MA30) of 202.46 and the 50-day moving average (MA50) of 198.73, suggesting bearish sentiment in the short to medium term. The recent high of 217.43 and low of 172.03 over the last 60 days indicate a range-bound market. Directional bias leans bearish due to the price being below key moving averages and the RSI indicating potential weakness. Suggested entry point is around $196.50, with a stop loss at $192.00 to limit downside risk. Target 1 is set at $202.00, aligning with the MA30, while Target 2 is at $210.00, near the 60D high. This strategy allows for a potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:19 AM
$THC is currently trading at $197.96, showing a neutral market context with an RSI of 44.18, indicating a lack of momentum. The price is below both the 30-day moving average (MA30) of 202.46 and the 50-day moving average (MA50) of 198.73, suggesting bearish sentiment in the short to medium term. The recent high of 217.43 and low of 172.03 over the last 60 days indicate a range-bound market. Directional bias leans bearish due to the price being below key moving averages and the RSI indicating potential weakness. Suggested entry point is around $196.50, with a stop loss at $192.00 to limit downside risk. Target 1 is set at $202.00, aligning with the MA30, while Target 2 is at $210.00, near the 60D high. This strategy allows for a potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 10 at 6:35 PM
$THC beats on Q3 earnings — yet the stock slides 5%. ⚠️ Higher revenues and solid segment growth drove the profit beat, but escalating costs are keeping investors cautious. See why strong results weren’t enough to lift the stock 👉 https://www.zacks.com/stock/news/2788824/tenet-healthcare-shares-down-5-despite-q3-earnings-beat?cid=sm-stocktwits-2-2788824-teaser-20368&ADID=SYND_STOCKTWITS_TWEET_2_2788824_TEASER_20368
0 · Reply
ZacksResearch
ZacksResearch Nov. 10 at 5:35 PM
$THC falls 5% post-Q3 earnings — what's driving the dip? 📉 Despite beating EPS estimates by 11.1% and raising 2025 revenue guidance, rising operating costs, especially in supplies, are weighing on the stock. See the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2788824/tenet-healthcare-shares-down-5-despite-q3-earnings-beat?cid=sm-stocktwits-2-2788824-body-20335&ADID=SYND_STOCKTWITS_TWEET_2_2788824_BODY_20335
0 · Reply
cubie
cubie Nov. 10 at 4:43 PM
$HUM has ZERO ACA marketplace exposure but it still down -4% , scam street saying these companies will lose millions of customers after Republicans killed the ACA tax subsidies meaning poor folks will go without insurance instead. thats all. $OSCR $UNH also why hospitals stocks tank too $HCA $THC
2 · Reply
abman54
abman54 Nov. 10 at 2:10 PM
$THC dang trump
1 · Reply
Latest News on THC
Tenet to Report Its Third Quarter 2025 Results on October 28th

Sep 30, 2025, 9:00 AM EDT - 6 weeks ago

Tenet to Report Its Third Quarter 2025 Results on October 28th


Tenet to Report its Second Quarter 2025 Results on July 22nd

Jun 23, 2025, 9:00 AM EDT - 5 months ago

Tenet to Report its Second Quarter 2025 Results on July 22nd


Hospital Stocks Get Reprieve on Medicaid Spending, for Now

May 13, 2025, 6:30 AM EDT - 6 months ago

Hospital Stocks Get Reprieve on Medicaid Spending, for Now

HCA UHS


Tenet Reports Strong First Quarter 2025 Results

Apr 29, 2025, 6:45 AM EDT - 7 months ago

Tenet Reports Strong First Quarter 2025 Results


Final Trade: BABA, INTC, NFLX, THC

Apr 17, 2025, 6:27 PM EDT - 7 months ago

Final Trade: BABA, INTC, NFLX, THC

INTC NFLX BABA


Final Trade: DAL, C, NVDA, THC

Apr 15, 2025, 6:21 PM EDT - 7 months ago

Final Trade: DAL, C, NVDA, THC

NVDA C DAL


Tenet to Report Its First Quarter 2025 Results on April 29th

Apr 9, 2025, 9:00 AM EDT - 7 months ago

Tenet to Report Its First Quarter 2025 Results on April 29th


Tenet Healthcare: Active Returns Analysis

Mar 20, 2025, 12:21 PM EDT - 8 months ago

Tenet Healthcare: Active Returns Analysis


ValuEngine's Top 10 Stocks For 2025

Jan 15, 2025, 1:05 PM EST - 10 months ago

ValuEngine's Top 10 Stocks For 2025

AFRM CCL CHWY CRDO CVNA DKNG DOCU


Tenet to Report its Fourth Quarter 2024 Results on February 12th

Jan 13, 2025, 9:00 AM EST - 10 months ago

Tenet to Report its Fourth Quarter 2024 Results on February 12th


Tenet Healthcare Stock: An Improved Option Here (Rating Upgrade)

Dec 30, 2024, 11:46 AM EST - 11 months ago

Tenet Healthcare Stock: An Improved Option Here (Rating Upgrade)


Tenet to Participate in the UBS Global Healthcare Conference

Oct 23, 2024, 9:00 AM EDT - 1 year ago

Tenet to Participate in the UBS Global Healthcare Conference


Tenet Completes Sale of Five Hospitals in Birmingham

Oct 1, 2024, 6:45 AM EDT - 1 year ago

Tenet Completes Sale of Five Hospitals in Birmingham


Top Value Stocks With Growth Prospects

Aug 29, 2024, 8:00 AM EDT - 1 year ago

Top Value Stocks With Growth Prospects

NRG REVG


PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:36 AM
$THC is currently trading at $196.66, with an RSI of 38.86 indicating potential oversold conditions. The price is below both the 30-day moving average (MA30) of 202.2 and the 50-day moving average (MA50) of 199.08, suggesting a bearish trend. The recent high of $217.43 and low of $177.36 over the past 60 days further illustrate a significant range, indicating volatility. Given the current metrics, the directional bias leans bearish, but the oversold RSI may provide a short-term bounce opportunity. Suggested trade plan: - Entry: $195.00 (anticipating a rebound) - Stop: $190.00 (to limit downside risk) - Target 1: $202.00 (near MA30) - Target 2: $207.00 (mid-range between recent high and current price) Monitor for any changes in momentum or market conditions that could affect these levels. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 11:10 PM
So far, several companies have been raising guidance this earnings season 🔥, a list that includes $AXP, $W, and $THC. 📈 https://www.zacks.com/stock/quote/AXP?q=axp&cid=sm-stocktwits-1-quote_overview-oc-21002&ADID=SYND_STOCKTWITS_TWEET_1_QUOTEOVERVIEW_OC_21002
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:58 PM
JP Morgan has updated their rating for Tenet Healthcare ( $THC ) to Overweight with a price target of 230.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 3:34 PM
Wells Fargo updates rating for Tenet Healthcare ( $THC ) to Overweight, target set at 238 → 252.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:43 AM
$THC is currently trading at $197.96, showing a neutral market context with an RSI of 44.18, indicating a lack of momentum. The price is below both the 30-day moving average (MA30) of 202.46 and the 50-day moving average (MA50) of 198.73, suggesting bearish sentiment in the short to medium term. The recent high of 217.43 and low of 172.03 over the last 60 days indicate a range-bound market. Directional bias leans bearish due to the price being below key moving averages and the RSI indicating potential weakness. Suggested entry point is around $196.50, with a stop loss at $192.00 to limit downside risk. Target 1 is set at $202.00, aligning with the MA30, while Target 2 is at $210.00, near the 60D high. This strategy allows for a potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:19 AM
$THC is currently trading at $197.96, showing a neutral market context with an RSI of 44.18, indicating a lack of momentum. The price is below both the 30-day moving average (MA30) of 202.46 and the 50-day moving average (MA50) of 198.73, suggesting bearish sentiment in the short to medium term. The recent high of 217.43 and low of 172.03 over the last 60 days indicate a range-bound market. Directional bias leans bearish due to the price being below key moving averages and the RSI indicating potential weakness. Suggested entry point is around $196.50, with a stop loss at $192.00 to limit downside risk. Target 1 is set at $202.00, aligning with the MA30, while Target 2 is at $210.00, near the 60D high. This strategy allows for a potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 10 at 6:35 PM
$THC beats on Q3 earnings — yet the stock slides 5%. ⚠️ Higher revenues and solid segment growth drove the profit beat, but escalating costs are keeping investors cautious. See why strong results weren’t enough to lift the stock 👉 https://www.zacks.com/stock/news/2788824/tenet-healthcare-shares-down-5-despite-q3-earnings-beat?cid=sm-stocktwits-2-2788824-teaser-20368&ADID=SYND_STOCKTWITS_TWEET_2_2788824_TEASER_20368
0 · Reply
ZacksResearch
ZacksResearch Nov. 10 at 5:35 PM
$THC falls 5% post-Q3 earnings — what's driving the dip? 📉 Despite beating EPS estimates by 11.1% and raising 2025 revenue guidance, rising operating costs, especially in supplies, are weighing on the stock. See the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2788824/tenet-healthcare-shares-down-5-despite-q3-earnings-beat?cid=sm-stocktwits-2-2788824-body-20335&ADID=SYND_STOCKTWITS_TWEET_2_2788824_BODY_20335
0 · Reply
cubie
cubie Nov. 10 at 4:43 PM
$HUM has ZERO ACA marketplace exposure but it still down -4% , scam street saying these companies will lose millions of customers after Republicans killed the ACA tax subsidies meaning poor folks will go without insurance instead. thats all. $OSCR $UNH also why hospitals stocks tank too $HCA $THC
2 · Reply
abman54
abman54 Nov. 10 at 2:10 PM
$THC dang trump
1 · Reply
labibaouf
labibaouf Nov. 5 at 9:19 PM
$THC hospitals will be the biggest beneficiaries of AI adoption. profit will climb dramatically. This one is the leader.
0 · Reply
ern1in
ern1in Nov. 5 at 1:26 PM
$THC 160 range
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 3 at 10:39 PM
0 · Reply
labibaouf
labibaouf Nov. 3 at 6:44 PM
$THC late in the day run off
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Nov. 3 at 3:34 PM
$THC Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $240
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 3:33 PM
Truist Securities has updated their rating for Tenet Healthcare ( $THC ) to Buy with a price target of 240.
0 · Reply
IN0V8
IN0V8 Nov. 3 at 3:28 PM
$THC Buy Mizuho raises target price to $235 from $225 Truist Securities raises target price to $240 from $225
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 29 at 7:48 PM
$THC Share Price: $209.34 Contract Selected: Feb 20, 2026 $210 Calls Buy Zone: $15.39 – $19.01 Target Zone: $28.24 – $34.51 Potential Upside: 73% ROI Time to Expiration: 113 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
labibaouf
labibaouf Oct. 29 at 2:16 PM
$THC yesterday was the time to buy this one
0 · Reply
Estimize
Estimize Oct. 28 at 6:15 PM
$THC reported 3.70 EPS and 5,289 revenue for Q3. http://www.estimize.com/intro/thc?chart=historical&metric_name=eps&utm_content=THC&utm_med
0 · Reply
labibaouf
labibaouf Oct. 28 at 3:02 PM
$THC might close even tonight. ER report was very good.
0 · Reply
osubuckeye
osubuckeye Oct. 28 at 2:53 PM
$THC Good summary of pros and cons https://x.com/finsee_main/status/1983134041369911594?s=46&t=2bTzSlLR3E7-yCRBsdd8YQ
0 · Reply